Oct 24 (Reuters) - ResMed (RMD.N), opens new tab beat Wall Street estimates for quarterly profit on Thursday, driven by strong demand for its devices used for sleep apnea treatment. Shares of the ...
April 25 (Reuters) - ResMed (RMD.N), opens new tab beat Wall Street estimates for quarterly profit on Wednesday due to strong demand for its sleep apnea devices, sending shares 9% higher in extended ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback